0001214659-20-010742.txt : 20201229 0001214659-20-010742.hdr.sgml : 20201229 20201229175344 ACCESSION NUMBER: 0001214659-20-010742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201224 FILED AS OF DATE: 20201229 DATE AS OF CHANGE: 20201229 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daniels Mark CENTRAL INDEX KEY: 0001753840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38720 FILM NUMBER: 201423526 MAIL ADDRESS: STREET 1: C/O TWIST BIOSCIENCE CORPORATION STREET 2: 455 MISSION BAY BOULEVARD SOUTH CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Twist Bioscience Corp CENTRAL INDEX KEY: 0001581280 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462058888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 800-719-0671 MAIL ADDRESS: STREET 1: 681 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 marketforms-50726.xml PRIMARY DOCUMENT X0306 4 2020-12-24 0001581280 Twist Bioscience Corp TWST 0001753840 Daniels Mark C/O TWIST BIOSCIENCE CORPORATION 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 false true false false See Remarks Common Stock 2020-12-24 4 M false 620 23.33 A 69407 D Common Stock 2020-12-24 4 S false 620 167.79 D 68787 D Common Stock 2020-12-28 4 M false 377 8.82 A 69164 D Common Stock 2020-12-28 4 S false 377 167.10 D 68787 D Employee Stock Option (right to buy) 23.33 2020-12-24 4 M false 620 0 D 2029-10-23 Common Stock 620 21095 D Employee Stock Option (right to buy) 8.82 2020-12-28 4 M false 377 0 D 2027-09-28 Common Stock 377 3392 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on September 15, 2020. 25% of the shares subject to the option vested on October 24, 2020, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Senior Vice President, Chief Legal Officer, Chief Ethics and Compliance Officer, and Secretary /s/ William Solis, as Attorney-in-Fact for Mark Daniels 2020-12-29